10th IAS Conference on HIV Science

July 21-24, 2019; Mexico City, Mexico
CCO is the official provider of online scientific analysis for the 2019 International AIDS Society meeting through Capsule Summaries, downloadable slides, rapid expert Webinars, and ClinicalThought commentaries.
Brenda E. Crabtree Ramírez, MD
Carlos del Rio, MD
Cristina Mussini, MD
Anton L. Pozniak, MD, FRCP
Jürgen K. Rockstroh, MD
Paul E. Sax, MD


Here’s my summary of new data to look forward to from IAS 2019.

Anton L. Pozniak, MD, FRCP Released: July 16, 2019

Why IAS 2019 data provided me with new tools for my practice and a sense of hope that we can beat HIV.

Brenda E. Crabtree Ramírez, MD Released: August 26, 2019

Patient-reported outcomes on long-acting injectable cabotegravir plus rilpivirine reinforce high treatment acceptance and satisfaction. Here’s my take on what this means for patients and practice.

Paul E. Sax, MD Released: September 12, 2019

Download slide highlights of key studies addressing current issues in HIV care, as reported at this important annual conference.

Brenda E. Crabtree Ramírez, MD Anton L. Pozniak, MD, FRCP Released: August 2, 2019

Listen to downloadable audio from a live Webinar reviewing the most clinically relevant new HIV data on NTD risk in pregnancy, PrEP, first-line therapy, and switch strategies.

Carlos del Rio, MD Released: August 26, 2019

European Perspectives

In this downloadable audio from a live Webinar, gain clinical insights on new HIV data presented at IAS 2019. Areas of focus include NTD risk in pregnancy, PrEP, first-line therapy, switch strategies, and STI prevalence among MSM.

Jürgen K. Rockstroh, MD Released: August 20, 2019

Updated first-line and switch data reinforce the noninferiority of DTG/3TC compared with 3-drug regimens. How will these results affect practice? Here’s my take.

Jürgen K. Rockstroh, MD Released: August 20, 2019

Updated information regarding neural tube defects and weight gain with ART was presented at IAS 2019. These data are important to my practice. Here’s why.

Cristina Mussini, MD Released: September 4, 2019

Partnership Information

IAS 2019 Media Partner Logo 



IAS 2019 conference organizers are using social media to communicate with delegates attending the meeting and with those following the conference from home.

Social Media
Join the #IAS2019 conversation

Facebook Social Media Icon  Twitter Icon  Youtube Icon  

Facebook, Twitter, YouTube, and Instagram.

For more information about these resources and IAS 2019, go to www.ias2019.org.

NAM is the official provider of online scientific news reporting for IAS 2019 via its Web site and summary email bulletins during the conference.

To view the coverage and to sign up for the bulletins (also available in French, Portuguese, Spanish, and Russian), go to www.aidsmap.com.

Conference News – Reported by NAM

Provided by USF

USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602

(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)

Produced in collaboration with
IAS 2019 Media Partner Logo
Educational grant provided by:
Gilead Sciences
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?